Dear Derm Authority: Full Skin Exam with No History – how do you handle?
On initial visits when patients state coming in for only "skin cancer screening", and not aware of any issues, or requests "full skin exam" and no significant personal or family history, how do you handle these?
My office staff is great at briefing patients – We tell them to make sure to note any new or changing growths on the skin. It is important to know your family history of melanoma an …
On initial visits when patients state coming in for only "skin cancer screening", and not aware of any issues, or requests "full skin exam" and no significant personal or family history, how do you handle these?
My office staff is great at briefing patients – We tell them to make sure to note any new or changing growths on the skin. It is important to know your family history of melanoma an … Continue reading "Dear Derm Authority: Full Skin Exam with No History – how do you handle?"
Dear Derm Authority: What are the more common complaints or maladies that you see in skin of color patients and what resources do you recommend for new practitioners who want expand their understanding of them?
The US population is growing and evolving and the clinical profile of the average patient presenting to the dermatologist is changing. One in three Americans self-identify as member of a … 
Catch up on your JDD reading with highlights from the August issue, Special Focus: Psoriasis.
Strober, Bagel, and Lebwohl et al present Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study READ NOW
The Static Physician’s Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Ps … 
Go superpotent or go home. The utility and safety of Class 1 topical steroids.
Dr. Tina Bhutani and Dr. Adam Friedman
In this edition of the JDD Podcast, Ask the Investigator, host Dr. Adam Friedman digs deep with UCSF Assistant Professor of Dermatology Dr. Tina Bhutani to powerlift the most up to date safety data on Class 1 superpotent topical steroids from her study entitled "Update on the … 
I saw a young man for eczematized tinea pedis. I prescribed Castellanbi's paint.
He returned for his follow up, and was pleased that he was much better.
I asked how often he was applying the medication and he looked at me quizzically. He said he wasn't putting the liquid on - he was taking it orally. Frantically fearing that I had mis-written the prescription, I asked … 